Sage Therapeutics Inc (NASDAQ:SAGE)’s traded shares stood at 1.1 million during the latest session, with the company’s beta value hitting 0.26. At the last check
Sage Therapeutics Inc (NASDAQ:SAGE) has a beta value of 0.17 and has seen 1.78 million shares traded in the last trading session. The SAGE stock
During the last session, Sage Therapeutics Inc (NASDAQ:SAGE)’s traded shares were 2.87 million, with the beta value of the company hitting 0.17. At the end
In today’s recent session, 14.7 million shares of the Sage Therapeutics Inc (NASDAQ:SAGE) have been traded, and its beta is 0.17. Most recently the company’s
In last trading session, Sage Therapeutics Inc (NASDAQ:SAGE) saw 0.77 million shares changing hands with its beta currently measuring 0.17. Company’s recent per share price
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne